Amber Fontenot-Ferriss, MD
Obstetrics & Gynecology · Arvada, CONPI 1124394192
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,546 of the $2,959 with a category attached, or 86.0%. It is spread thinly across 33 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $726 and has fallen 57.4% since, to $309 in 2025.
Across 130 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$500
- Covidien LP$344
- Astellas Pharma US Inc$327
- Mayne Pharma Commercial LLC$219
- Hologic Sales And Service, LLC$191
- Bayer$179
- plus $1K from 27 others
What the payments were for
- Consulting fees$32511%
- Food & beverage$2,54686%
- Education$883%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $500 |
| Covidien LP | 2 | $344 |
| Astellas Pharma US Inc | 12 | $327 |
| Mayne Pharma Commercial LLC | 8 | $219 |
| Hologic Sales And Service, LLC | 9 | $191 |
| Bayer | 8 | $179 |
| Organon | 7 | $135 |
| Merck | 7 | $105 |
| Pfizer | 5 | $95 |
| Exeltis, USA Inc. | 4 | $78 |
| Baxter Healthcare | 2 | $74 |
| Medtronic | 2 | $72 |
| Evofem Biosciences, Inc. | 3 | $63 |
| Avion Pharmaceuticals | 3 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Therapeuticsmd, Inc. | 3 | $48 |
| Ascend Therapeutics US, LLC | 3 | $45 |
| Monaghan Medical Corporation | 1 | $40 |
| Coopersurgical, Inc. | 2 | $35 |
| Shield Therapeutics Inc | 2 | $35 |
| Vertical Pharmaceuticals, LLC | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Millicent US Inc | 1 | $26 |
| Myovant Sciences Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
| LSI Solutions Inc | 1 | $22 |
| Mallinckrodt Enterprises LLC | 1 | $20 |
| Amgen | 1 | $18 |
| Visby Medical, Inc. | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Aspira Women's Health Inc | 1 | $13 |
How this compares
$2,959 in reported general payments places this provider in the 85th percentile of 705 obstetrics & gynecology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 73 | $6,340 |
| ProgesteroneProgesterone, Micronized | 55 | $3,861 |
| DottiEstradiol | 11 | $1,537 |
| Estradiol (Once Weekly)Estradiol | 14 | $1,468 |
| Clobetasol Propionate | 14 | $300 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Arvada
- John CraneLoveland$415K
- James LukbanEnglewood$175K
- Wayne FurrLonetree$106K
- William BrownDenver$76K
- Kristina TocceDenver$57K
- Jill LissAurora$57K
- Alison CowanLouisville$32K
- Emily LandersLittleton$28K
- Marisa ToddDurango$28K
- Ronald GibbsAurora$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.